2007 Brings 40+ New SOM Faculty
Chairs in Pediatrics, Pathology, Head List
|
This year more than 40 new faculty have joined the
School of
Medicine. The increase brings new expertise in cerebrovascular surgery, sleep disorders, and robotically-assisted surgery. The increase also adds to existing specialities such as Neonatology and Oncology/Hematology. Among the new faculty are two department chairs, Margaret McGovern, M.D., Ph.D.(Pediatrics), and Kenneth R. Shroyer, M.D., Ph.D. (Pathology), both of whom bring a vision for expanding departmental research and professional training.
Margaret McGovern, M.D.,Ph.D.
|
An expert on Niemann-Pick disease, Dr. McGovern is working to bring basic scientists and clinical researchers within the School to apply advances in genetics, pharamacology, nanotechnology and other areas to pediatric illnesses. Dr. McGovern is involved in professional training activities of the
American
Academy of Pediatrics, and she expects to bring additional training modules for students and residents in all 14 subspecialities.
Dr. Shroyer is an expert in Surgical and Cytopathology and recognized for translational studies in the development of novel molecular markers for treating cancer. He has launched the Pathology Translation Research Laboratory, a new core translational research program in the department. He plans to add experts in clinical chemistry, soft tissue pathology, and other surgical pathology subspecialties, all of which would provide further expertise and training in anatomic and clinical pathology.
Adding faculty remains an important component to expanding specialty care for patients, as well as for medical education, including clinical skills modules designed for medical students or special training for faculty:
Henry Woo, M.D.
|
Henry H. Woo, M.D., Director of the Cerebrovascular Center, brings his expertise as a neurosurgeon and neurointerventionalist to heighten treatment for areas such as cerebral aneurysms, endovascular management of acute stroke; and surgical, endovascular and radiosurgical treatment of cerebral arteriovenous malformations.
Rahuldev S. Bhalla, M.D.
|
The arrival Rahuldev S. Bhalla, M.D., Director, Robotics and Minimally Invasive Surgery, enables surgeons to learn first-hand how to perform robotic surgery for prostate cancer and other diseases with the newly acquired da Vinci® S HD™ Surgical System, a state-of-the-art robotic-assisted system that heightens surgeons’ abilities to perform minimally invasive surgery.
For a complete list of new faculty, see the link in New Faculty section.
© Copyright 2007 by Medical Center News
Top of Page
|
